Efalizumab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Efalizumab, covering 2006-09-29 to 2021-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis [Phase 3]